5 Things Chronic Illness Patients Should Know About the ‘California v. Texas’ Supreme Court Hearing
JUST IN
The outcome of another Affordable Care Act case going before the Supreme Court could have a big impact on people with pre-existing conditions. Here’s what to know.
More than half of patients are denied approval for proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i), according to research published in the journal Circulation. And that’s true even though many appear to meet labeled indicators, the data shows. “Although a combination of clinical characteristics increases the likelihood of approval, payer type is the most significant […]
GHLF recently worked with the University of Michigan’s Center for Value Based Insurance Design (V-BID) on a report about Copayment Assistance Programs.